Prot# CLDE225A2201: A Phase II, Randomized Double-Blind Study of Efficacy and Safety of Two Dose Levels of LDE225 in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/1/11 → 12/30/16

Funding

  • Novartis Pharmaceuticals Corporation (CLDE225A2201)